EMBR-21. CLINICALLY TRACTABLE OUTCOME PREDICTION OF GROUP 3/4 MEDULLOBLASTOMA BASED ON TPD52 IMMUNOHISTOCHEMISTRY: A MULTICOHORT STUDY
EMBR-21. 基于TPD52免疫组化对3/4组髓母细胞瘤临床可治疗结局的预测：一项多队列研究
期刊:Molecular Cell
影响因子:16.6
doi:10.1016/j.molcel.2013.03.010
Duttler, Stefanie; Pechmann, Sebastian; Frydman, Judith; Caro, Valentina Di; Lizama, Britney N; Cho, Eunah; Duong, Duc M; Pandey, Kiran; Blennow, Kaj; Zetterberg, Henrik; Levey, Allan I; Teunissen, Charlotte; Caggiano, Anthony O; Seyfried, Nicholas T; Hamby, Mary E; Delaidelli, Alberto; Dunham, Christopher; Santi, Maria Rita; Negri, Gian Luca; Triscott, Joanna; Zheludkova, Olga; Golanov, Andrey; Ryzhova, Marina; Okonechnikov, Konstantin; Schrimpf, Daniel; Stichel, Damian; von Deimling, Andreas; Kool, Marcel; Pfister, Stefan; Ramaswamy, Vijay; Korshunov, Andrey; Taylor, Michael; Sorensen, Poul
